Determination of the relative involvement of μ-opioid receptors in opioid-induced depression of respiratory rate by use of β-funaltrexamine

European Journal of Pharmacology

Volumn 87, Issue 1, 1983, Pages 1-6

  Ward, Susan J ^a   Takemori, A E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antinociception; Ethylketazocine; Morphine; Receptors; Respiratory depression; D Ala2,D Leu5 enkephalin; Funaltrexamine

Indexed keywords

ANTINOCICEPTIVE AGENT; BETA FUNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ETHYLKETAZOCINE; MORPHINE; OPIATE RECEPTOR; RECEPTOR;

ANIMAL EXPERIMENT; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; MOUSE; NONHUMAN; RESPIRATION DEPRESSION; RESPIRATORY SYSTEM;

ANALGESICS; ANIMAL; DEPRESSION, CHEMICAL; DRUG INTERACTIONS; FEMALE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NALOXONE; NALTREXONE; NARCOTICS; REACTION TIME; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; RESPIRATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020701371     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(83)90043-2     Document Type: Article

References (31)

1. Stress-induced increase in opiate peptides: Concurrent analgesia and its partial reversal by naloxone
2. Irritating properties of airborne materials to the upper respiratory tract
3. The analgesic and respiratory depressant activities of N-allyl noretorphine and morphine in the mouse
4. A method for determining loss of pain sensation
5. The effects of morphine- and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog
6. Respiratory and cardiovascular effect of met-enkephalin applied to the ventral surface of the brain stem
7. 2-methionine-enkephalinamide, and methionine enkephalin injected into the lateral ventricle and the pontomedullary subarachnoid space
8. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse
9. CNS effects of pentazocine and other analgesic antagonists
10. The type of analgesic-receptor interaction involved in certain analgesic assays
11. Hypophysectomy alters cardiorespiratory variables; central effects of pituitary endorphins in shock
12. Narcotic analgesics and antagonists
13. Morphine antagonists as analgesics in man
14. Effect of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with μ- and δ-receptors
15. Endogenous opioid peptides: Multiple agonists and receptors
16. The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog
17. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine-pretreatment
18. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia
19. β-endorphin: effects on respiratory regulation
20. Beta-endorphin immunoreactivity in rat plasma: variations in response to different physical stimuli
21. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities
22. Enkephalin-like character and analgesia
23. Regional dissociation of β-endorphin and enkephalin contents in rat brain and pituitary
24. Opiate receptors and opioid peptides
25. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone
26. A classification of opiate receptors that mediate antinociception in animals
27. Binding characteristics of the specific μ antagonist, β-FNA, the fumaramate methyl ester derivative of naltrexone
28. Pharmacological characterization in vivo of the novel opiate β-funaltrexamine (β-FNA)
29. Pharmacological profile of β-finaltrexamine (β-FNA) and β-chlornaltexamine (β-CNA) on the mouse vas deferens preparation
30. Tolerance, cross-tolerance and dependence to μ- and δ-agonists in vivo and in vitro